These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 3691760

  • 21. Alpha-interferon activates the natural killer system in patients with hairy cell leukemia.
    Semenzato G, Pizzolo G, Agostini C, Ambrosetti A, Zambello R, Trentin L, Luca M, Masciarelli M, Chilosi M, Vinante F.
    Blood; 1986 Jul; 68(1):293-6. PubMed ID: 3719101
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Alpha-interferon activated cytotoxic lymphocytes in hairy cell leukemia patients: evaluation of cytotoxic events.
    Trentin L, Ambrosetti A, Zambello R, Agostini C, Masciarelli M, Vinante F, Chilosi M, Pizzolo G, Cetto G, Semenzato G.
    Leuk Res; 1987 Jul; 11(9):843-7. PubMed ID: 3499539
    [Abstract] [Full Text] [Related]

  • 24. Hematologic and immunologic changes in hairy cell leukemia patients treated with alpha interferon.
    Turhan AG, Eaves CJ, Connors JM, Eaves AC, Karim KA, Silver KB.
    J Biol Regul Homeost Agents; 1988 Jul; 2(4):157-65. PubMed ID: 2907963
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Modulation of the expression of major histocompatibility antigens on splenic hairy cells--differential effect upon in vitro treatment with alpha-2b-interferon, gamma-interferon, and interleukin-2.
    Gressler VH, Weinkauff RE, Franklin WA, Golomb HM.
    Blood; 1988 Sep; 72(3):1048-53. PubMed ID: 3137982
    [Abstract] [Full Text] [Related]

  • 27. Strategy for the treatment of hairy cell leukemia.
    Porzsolt F, Raghavachar A, Digel W, Raghavachar A, Bartram CR, Heimpel H.
    Leukemia; 1987 Apr; 1(4):334-7. PubMed ID: 3669758
    [Abstract] [Full Text] [Related]

  • 28. Mechanisms accounting for the defective natural killer activity in patients with hairy cell leukemia.
    Trentin L, Zambello R, Agostini C, Ambrosetti A, Chisesi T, Raimondi R, Bulian P, Pizzolo G, Semenzato G.
    Blood; 1990 Apr 01; 75(7):1525-30. PubMed ID: 2317560
    [Abstract] [Full Text] [Related]

  • 29. Soluble interleukin-2 receptors in the sera of patients with hairy cell leukemia: relationship with the effect of recombinant alpha-interferon therapy on clinical parameters and natural killer in vitro activity.
    Chilosi M, Semenzato G, Cetto G, Ambrosetti A, Fiore-Donati L, Perona G, Berton G, Lestani M, Scarpa A, Agostini C.
    Blood; 1987 Nov 01; 70(5):1530-5. PubMed ID: 3117133
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Responses of hairy cell leukemia cells to a recombinant alpha-2 interferon in vitro and in vivo: correlation between formation of tubuloreticular structures and clinical parameters.
    Hiraoka A, Golomb HM.
    J Biol Response Mod; 1986 Jun 01; 5(3):270-81. PubMed ID: 3723140
    [Abstract] [Full Text] [Related]

  • 33. In vivo induction of proteins during therapy of hairy cell leukemia with alpha-interferon.
    Samuels BL, Golomb HM, Brownstein BH.
    Blood; 1987 Jun 01; 69(6):1570-3. PubMed ID: 3580566
    [Abstract] [Full Text] [Related]

  • 34. Modulation of immune functions by long-term treatment with recombinant interferon-alpha 2 in a patient with hairy-cell leukemia.
    Teichmann JV, Sieber G, Ludwig WD, Ruehl H.
    J Interferon Res; 1988 Feb 01; 8(1):15-24. PubMed ID: 3259251
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Analysis of natural killer cell cytotoxicity of cancer patients treated with recombinant interferon.
    Lotzová E, Savary CA, Quesada JR, Gutterman JU, Hersh EM.
    J Natl Cancer Inst; 1983 Nov 01; 71(5):903-10. PubMed ID: 6580490
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.